Core Viewpoint - The company has issued a stern statement regarding unauthorized products that mimic its in-house formulations, emphasizing the potential health risks to children and the need for parents to be vigilant in distinguishing legitimate products from counterfeit ones [1][2]. Group 1: Company’s In-House Formulations - The in-house formulations of the company are legally approved and regulated medical institution preparations, including products like "Fu Le Cream" and "Dimethicone Cream," which have received the necessary approvals from the Beijing Drug Administration [1]. - These formulations are developed by the company with standardized quality management and are only available through its outpatient services, internet consultations, and approved partner medical institutions with a physician's prescription [1]. Group 2: Risks of Infringing Products - Infringing products often exhibit characteristics such as similar or nearly identical names, packaging, and misleading claims like "new version" or "special supply," which can mislead parents [2]. - These products lack legitimate approval credentials and may provide false advertising, exaggerating their efficacy or misrepresenting themselves as medical products [2]. - The formulations of these infringing products may be altered, using substandard ingredients, leading to potential health risks for children [2]. Group 3: Legal Actions Against Infringement - The company has engaged a professional legal team to initiate actions against identified infringing manufacturers and sellers, including administrative complaints and civil lawsuits to halt infringement and seek damages [3]. - Reports of non-compliant sales channels will be submitted to regulatory authorities for investigation and enforcement [3]. - A reporting channel for infringement leads has been established, encouraging public vigilance and cooperation [3]. Group 4: Authorized Purchase Channels - Parents are advised to obtain medications only from the company’s medical center or approved partner institutions, ensuring prescriptions are provided by licensed medical professionals [4]. - The company has not authorized any third parties for the promotion or sale of its in-house formulations, reinforcing the importance of using official channels for medication [4].

Core Viewpoint - The Capital Pediatric Research Institute and the Capital Medical University Affiliated Capital Children's Medical Center have identified unauthorized products in the market that closely resemble their approved formulations, leading to illegal promotion and sales that mislead parents in product selection [1][2]. Group 1: Unauthorized Products - Unauthorized products have been found in the market that use similar or highly similar names, packaging, and labeling to the institute's formulations, including cosmetics, medical devices, and disinfectants [1]. - These infringing products lack legal approval, have unclear formulations, and pose significant health risks to children due to potential differences in ingredients, processes, and quality control [1][2]. Group 2: Legal Actions - The institute has engaged a professional legal team to initiate a special rights protection action against the unauthorized use of their product names and formulations [3].

Core Insights - The Capital Pediatric Research Institute has lifted the restriction that only patients with a first visit history at the hospital can use online follow-up services, now allowing patients with prior visits to other hospitals to apply for online consultations [1][2] Group 1: New Features - The hospital has introduced three new features to enhance patient service experience: "cross-hospital follow-up," "self-service pre-order," and "dual appointment for online and offline services" [1] - The "online cross-hospital follow-up" feature allows patients with valid prescriptions or test reports from other medical institutions within the last six months to apply for online consultations at the hospital [1] Group 2: Medication and Services - Most common and chronic disease medications can be purchased online, with the exception of certain high-risk medications, and prescriptions can be delivered to patients' homes [2] - The online consultation and medication purchase services are now covered by medical insurance for local patients in Beijing [2] Group 3: Monitoring and Testing - The hospital has launched a "self-service pre-order" function for patients requiring regular monitoring, allowing parents to select necessary tests online before visiting the hospital [2] - This feature is currently available in the nephrology department, supporting nearly 20 common test items, with plans for expansion to other clinical departments [2]